...
首页> 外文期刊>Vaccine >Purification of phocid herpesvirus type 1 glycoproteins B and D and pilot studies of immunogenicity in mice
【24h】

Purification of phocid herpesvirus type 1 glycoproteins B and D and pilot studies of immunogenicity in mice

机译:幽门螺杆菌1型糖蛋白B和D的纯化和小鼠免疫原性的初步研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the process of developing a subunit vaccine against phocid herpesvirus type 1, we have cloned and expressed the glycoproteins B and D (gB and gD) of phicid herpesvirus type 1, using an eukaryotic baculovirus expression system. To establish the proof of concept, candidate iscom vaccines based on these affinity-purified proteins either alone or in combination, were tested for their immunogenicity in BALB/C mice. Mice immunised with a combination of gB and gD developed higher antibody and proliferative T cell responses against PhHV-1 than those immunised with gB or gD alone. The corresponding antibody and T cell proliferative responses were higher against PhHV-1 than against FHV. These data favour further testing of these candidate vaccines based on gB and gD in the FHV-cat model.
机译:在开发针对1型拟疱疹病毒的亚单位疫苗的过程中,我们已经使用真核杆状病毒表达系统克隆并表达了1型拟疱疹病毒的糖蛋白B和D(gB和gD)。为了建立概念验证,测试了基于这些亲和纯化蛋白的单独或组合候选艾斯康疫苗,它们在BALB / C小鼠中的免疫原性。与单独用gB或gD免疫的小鼠相比,用gB和gD组合免疫的小鼠对PhHV-1的抗体和增殖性T细胞应答更高。与PhHV-1相比,针对PhHV-1的相应抗体和T细胞增殖反应更高。这些数据有助于在FHV-cat模型中基于gB和gD进一步测试这些候选疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号